Innomech celebrates eight-year partnership with Capsugel

Innomech was first appointed in 2001 to advise on and help develop a commercial machine based on the Xcelodose patented micro-dosing technology and system concepts. The first Xcelodose Precision Powder Micro-dosing Systems proved so successful that the company was retained to build and install further units.

Capsugel's patented Xcelodose system is now used routinely by major pharmaceutical companies and contract research organisations to fill capsules with pure pharmaceutical powders for use in clinical trials or for small-scale production. In addition to offering repeat build, Innomech now provides full installation, on-site training, testing and after-sales support for the Xcelodose system.

David Edwards, Director of Pharmaceutical Technology at Capsugel, comments: "GB Innomech is an important part of Capsugel's global operation and has built, installed and supports multiple Xcelodose systems across the world. Innomech's dedicated Xcelodose System Factory Support team, system development skills and specialist knowledge of pharmaceutical automation have been invaluable in helping establish the Xcelodose system as a market winner and establishing solid relationships with our customers."

In addition to providing a complete factory support service, Innomech has helped improve the performance and production efficiency of the Xcelodose system and has contributed to increasing the range of accessories and parts offered to Capsugel's Xcelodose system customers. In 2008, Capsugel briefed Innomech to devise a high-performance flow hood to enclose the Xcelodose system specifically for handling potent drugs in safety. Innomech designed Capsugel's Xcelohood Containment System from first principles to meet an exacting specification, yet it is easy to set up, use and maintain, and the whole cabinet can be relocated within minutes if required.